View Author
scopus: 35236335100

Bruinse, H.W.

(Hein Bruinse)


pregnancy women study preeclampsia hellp syndrome birth preterm birth delivery preterm outcome early-onset preeclampsia syndrome tlr 4 hellp polyhydramnio group netherland early-onset patient analysis trial centre obstetric history university idiopathic polyhydramnios hospital children preterm delivery caproate effect model recurrence risk level allelic variants hydroxyprogesterone progesterone obstet bmc pregnancy 17␣- hydroxyprogesterone caproate disease variant morbidity gynecol department number treatment recurrence gynaecology plasma health control nod 2 idiopathic result fibrinogen infant 17␣- plasma levels placebo childbirth prediction model trimester allelic pessary 34 weeks monitoring measure gestation prediction receptor preterm birth rate length interval hypertension disorder abnormality weight prevention center




6 Most Recent Publications

17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trial (Article)
Lim, A.C. Schuit, S.C.E. Kars, M.M. Kwee, A. Van Oirschot, C.M. Pampus, M.G. van Papatsonis, D.N.M. Porath, M. Spaanderman, M.E.A. Willekes, C. Wilpshaar, J. Mol, B.W.J. Bloemenkamp, K.W.M. Bruinse, H.W. Bernardus, R.E. Duvekot, J.J. Erwich, J.J.H.M. Eyck, J. van Groenwold, R.H.H. Hasaart, T.H.M. Hummel, P.
2011-09-01
Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study) (Article)
Delahaije, D.H.J. Kuijk, S.M.J. van Eyck, J. van Pampus, M.G. van Hoeven, M.A.B.H.M. van der Smits, L.J. Dirksen, C.D. Sep, S.J.S. Peeters, L.L. Spaanderman, M.E.A. Bruinse, H.W. Wit-Zuurendonk, L.D. de Post, J.A.M. van der Duvekot, J.J.
2010-10-11
Idiopathic polyhydramnios and postnatal findings (Article)
Dorleijn, D.M.J. Cohen-Overbeek, T.E. Groenendaal, F. Bruinse, H.W. Stoutenbeek, P.
2009-11-06
Pessaries in multiple pregnancy as a prevention of preterm birth: The ProTwin trial (Article)
Hegeman, M.A. Bekedam, D.J. Spaanderman, M.E.A. Porath, M. Eyck, J. van Haak, M.C. Pampus, M.G. van Bruinse, H.W. Mol, B.W.J. Bloemenkamp, K.W.M. Kwee, A. Papatsonis, D.N.M. Post, J.A.M. van der Lim, A.C. Scheepers, H.C.J. Willekes, C. Duvekot, J.J.
2009-09-17
Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome (Article)
Rijn, B.B. van Franx, A. Steegers-Theunissen, R.P.M. Groot, C.J.M. de Bertina, R.M. Pasterkamp, G. Voorbij, H.A.M. Bruinse, H.W. Roest, M.
2008-04-02
Progesterone for the prevention of preterm birth in women with multiple pregnancies: The AMPHIA trial (Article)
Lim, A.C. Bloemenkamp, K.W.M. Santema, J.G. Scheepers, H.C.J. Schöls, W. Vandenbussche, F.P.H.A. Wouters, M.G.A.J. Bruinse, H.W. Boer, K. Duvekot, J.J. Erwich, J.J.H.M. Hasaart, T.H.M. Hummel, P. Mol, B.W.J. Offermans, J.P.M. Van Oirschot, C.M.
2007-06-19